Estrogen receptor and breast cancer

Seminars in Cancer Biology

Volumn 11, Issue 5, 2001, Pages 339-352

  Sommer, Stephanie ^a   Fuqua, Suzanne A W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antiestrogens; Breast cancer; Co regulatory factors; Estrogen receptor

Indexed keywords

4 [4 METHYL 2 [4 [2 (1 PIPERIDINYL)ETHOXY]PHENYL] 7 PIVALOYLOXY 2H 1 BENZOPYRAN 3 YLPHENYL] PIVALATE; ACOLBIFENE; ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RALOXIFENE; TAMOXIFEN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; DRUG RECEPTOR BINDING; HORMONE RESISTANCE; HUMAN; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034751220     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2001.0389     Document Type: Article

References (84)

1. On the treatment of inoperable cases of carcinogen of the mamma: Suggestions for a new method of treatment with illustrative cases
2. Biological features of human premalignant breast disease
3. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06
4. Functional domains of the human estrogen receptor
5. The nuclear hormone receptor gene superfamily
6. A 13bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor
7. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
8. The carboxy-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists
9. Identification of a third autonomous activation domain within the human estrogen receptor
10. Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes
11. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor
12. Estrogen receptor domains E and F: Role in dimerization and interaction with coactivator RIP140
13. Oestrogen receptor facilitates the formation of preinitiation complex assembly: Involvement of the general transcription factor TFIIB
14. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation
15. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors
16. Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1
17. Identification of a negative regulatory function for steroid receptors
18. A regulatory role for RIP140 in nuclear receptor activation
19. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
20. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
21. Nuclear receptor coregulators: Cellular and molecular biology
22. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-Hydroxytamoxifen
23. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein
24. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
25. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
26. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens
27. Expression of a repressor of estrogen receptor activity in human breast tumors: Relationship to some known prognostic markers
28. The transcriptional coactivators p300 and CBP are histone acetyltransferases
29. The histone acetylase PCAF is a nuclear receptor coactivator
30. Steroid receptor coactivator-1 is a histone acetyltransferase
31. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression
32. II70
33. p300 is a component of an estrogen receptor coactivator complex
34. Phosphorylation of the human estrogen receptor. Identification of hormone- regulated sites and examinations of their influence on transcriptional activity
35. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
36. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner
37. Functional synergy between the transcription factor Sp1 and the estrogen receptor
38. Cross-talk between nuclear factor-κB and the steroid hormone receptors: Mechanisms of mutual antagonism
39. Transcriptional activation of insulin-like growth factor-binding protein-4 by 17β-estradiol in MCF-7 cells: Role of estrogen receptor-Sp1 complexes
40. Mechanism of estrogen activation of c-myc oncogene expression
41. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization
42. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I
43. Neurotransmitters activate the human estrogen receptor in a neuroblastoma cell line
44. The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells
45. CDK-independent activation of estrogen receptor by cyclin D1
46. The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer
47. Estrogen receptor variants
48. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma
49. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression
50. Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors
51. Hypermethylation of the estrogen receptor alpha gene is not related to lack of receptor protein in human breast cancer
52. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer
53. Estrogen receptor mutations in tamoxifen-resistant breast cancer
54. An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer
55. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
56. Human estrogen receptor ligand activity inversion mutants: Receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens
57. A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions
58. Development of peptide antagonists that target estrogen receptor-cofactor interactions
59. ICI 182, 780 (FaslodexTM) development of a novel "pure" antiestrogen
60. Novel compounds inhibit estrogen formation and action
61. Antiestrogens - Tamoxifen, SERMs and beyond
62. Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor
63. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium
64. A potent specific pure antiestrogen with clinical potential
65. Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro
66. Antiestrogen ICI 164, 384 reduces cellular estrogen receptor content by increasing its turnover
67. Proteasome-dependent degradation of the human estrogen receptor
68. Estrogen, estrogen receptors and selective estrogen receptor modulators in human breast cancer
69. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
70. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy
71. Expression of nuclear receptor interacting TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer
72. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform
73. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2
74. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
75. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily
76. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha
77. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer
78. RAP46 is a negative regulator of glucocorticoid receptor action and hormone- induced apoptosis
79. Enhancement of human estrogen receptor activity by SPT6: A potential coactivator
80. Tip60 is a nuclear hormone receptor coactivator
81. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors
82. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators
83. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators
84. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator